Can caffeine disrupt sleep more in some people due to ADORA2A rs5751876?

Caffeine consumption widely impacts sleep, but individual responses vary significantly. Emerging genomic research highlights how specific genetic variations influence this sensitivity, allowing for personalized approaches to caffeine intake and sleep hygiene.

Mechanistic explanations

• Adenosine Receptor Blockade: Caffeine acts as a nonselective competitive antagonist of adenosine $A_1$ and $A_{2A}$ receptors. By occupying these receptors, it blocks endogenous adenosine—the biological signaling molecule responsible for building homeostatic sleep pressure during wakefulness.
• Disrupted Sleep Architecture: This receptor blockade directly suppresses slow-wave activity (SWA) and low-frequency non-rapid eye movement (NREM) delta power. This neurophysiological shift increases sleep onset latency, reduces sleep efficiency, and promotes shallower, fragmented sleep.

Genetic and clinical evidence

• Genotype-Specific Sleep Vulnerability: The ADORA2A rs5751876 single nucleotide polymorphism modulates how caffeine affects sleep. Individuals carrying the C allele (particularly the homozygous CC genotype) exhibit heightened vulnerability to caffeine-induced sleep disruption, showing elevated high-frequency beta activity and decreased slow-wave sleep homeostasis under EEG monitoring.
• T-Allele Dynamics: Carriers of the T allele (CT and TT genotypes) experience relative protection against sleep disruption at moderate caffeine doses of under 300 mg/day. However, this variation demonstrates a genetic dissociation; while the T allele protects sleep, it is strongly associated with an increased susceptibility to caffeine-induced anxiety. At high doses, caffeine overcomes these genetic differences entirely.

Bottom line

• Caffeine impairs sleep by blocking adenosine $A_1$ and $A_{2A}$ receptors and suppressing deep slow-wave activity. Individual sensitivity is heavily driven by the ADORA2A rs5751876 polymorphism, where the CC genotype increases vulnerability to insomnia, while the T allele offers sleep protection at moderate doses (<300 mg/day) but increases susceptibility to caffeine-induced anxiety.